G
Gyre Therapeutics, Inc.
GYRE · NASDAQ · Healthcare · 745M
Closing price
$7.04
+4.14% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
125.1×
Price / net assetsP/B
4.4×
Enterprise value / EBITDAEV/EBITDA
35.0×
Free cash flow yieldFCF yield
-0.0%
Return on equityROE
4.7%
Operating margin
9.9%
Net debt / EBITDAbalance-sheet strength
-2.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.